YEM Search

搜索结果

EFNA5

靶点ID:TCMBANKGE011832

靶点别名:AF1; EFL5; EPLG7; GLC1M; LERK7; RAGS

靶点描述:ephrin A5

染色体:5

染色体位置:5q21.3

靶点类型:protein-coding

HERB_ID:HBTAR001175

HGNC_Link:3225

OMIM_Link:601535

Ensembl_Link:ENSG00000184349

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN014003	zeta-carotene	LS-187070; xi-Carotene; CHEBI:28068; AC1NQXL2; BIWLELKAFXRPDE-WTXAYMOSSA-N; 2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,26,30-undecaene; C05430; (6E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,26,30-undecaene; all-trans-zeta-carotene; zeta-Carotene; Zeta-Carotin; 7,8,7',8'-tetrahydro-psi,psi-carotene; LS-187678; LMPR01070256; 13587-06-9; CHEBI:27362	C40H60	540.9 g/mol	CC(=CCCC(=CCCC(=CC=CC(=CC=CC=C(C)C=CC=C(C)CCC=C(C)CCC=C(C)C)C)C)C)C
TCMBANKIN040768	Phytoene	7,8,11,12,7',8',11',12'-octahydro-psi,psi-carotene; NSC378840; 540-04-5; 2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,14,16,18,22,26,30-nonaene; all-trans-phytoene; NSC 378840; C05413; Lycopene, 7,7',8,8',11,11',12,12'-octahydro-, all-trans-; phytoene; 13832-75-2; 7696-40-4; LMPR01070254; (6E,10E,14E,16E,18E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,14,16,18,22,26,30-nonaene; .psi.,.psi.-Carotene, 7,7',8,8',11,11',12,12'-octahydro-; psi,psi-Carotene, 7,7',8,8',11,11',12,12'-octahydro-; 7,7',8,8',11,11',12,12'-Octahydro-psi,psi-carotene; CHEBI:8191		545
TCMBANKIN057947	glucoside	SCHEMBL25601; FT-0626726; 136760-05-9; .beta.-D-Glucose; UNII-J4R00M814D; beta-glucose; 207381-EP2280021A1; 133947-06-5; beta-delta-Glucopyranose; MCULE-4260589665; CHEBI:15903; beta-d-(+)-glucose; BDBM50240803; 28905-12-6; MolPort-006-111-449; KB-277820; DB02379; D07ONX; 6-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetrol; SC-25121; NSC759603; (1->6)-beta-D-glucopyranan; 1,2-beta-D-Glucan; EINECS 207-756-2; beta-D-Glc; (1,2-beta-D-glucosyl)n; (2R,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol; .beta.-D-Glucopyranose; FT-0622903; NSC-759603; Beta-D-glucose anhydrous; b-D-Glucopyranose; CHEMBL1614854; beta-D-glucopyranose; W-202206; 1,5]; AC1L21QQ; C00221; Grape sugar; BG01505598; Galactitol,1,5-anhydro-1-C-phenyl-; G0047; 53991-51-8; 492-61-5; b-d-glucose; 9001-37-0; BGC; WQZGKKKJIJFFOK-VFUOTHLCSA-N; (1->3)-beta-D-glucan; CTK8F0914; AKOS016010209; DB-051616; AE-562/43459286; 207381-EP2280004A1; 50986-29-3; AK306225; (1->3)-beta-D-glucopyranan; TR-038298; beta-(1,3)-glucan; Curdlan; b-Glucose; .beta.-d-Glucose, anhydrous; ZINC3833800; CHEBI:27517; CHEBI:37671; FCH1120200; beta-Dextrose; (1->4)-beta-D-glucopyranan; (1->6)-beta-D-glucan; WURCS=1.0/1,0/[12122h; beta-D-glucose; (2R,3R,4S,5R,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol; (1->2)-beta-D-glucopyranan; Pharmakon1600-01300015; ZYMOSAN; AJ-45802; (+)-Glucose; CHEBI:18246; 207381-EP2280020A1; (1->2)-beta-D-glucan; b-Dextrose; 108942-17-2; (2R,3R,4S,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol; MFCD00063989; 492-64-8; CHEBI:27380; (1->4)-beta-D-glucan; anhydrous glucose; Glucose, (beta-D)-Isomer; J4R00M814D; Callose; beta-D-Glucopyranose, anhydrous; Beta-d-glucose, anhydrous; 128009-02-9; AX8115243;BGC	C6H12O6	180.16 g/mol	C(C1C(C(C(C(O1)O)O)O)O)O
TCMBANKIN058833	zeta-carotene	LS-187070; xi-Carotene; CHEBI:28068; AC1NQXL2; BIWLELKAFXRPDE-WTXAYMOSSA-N; 2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,26,30-undecaene; C05430; (6E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,26,30-undecaene; all-trans-zeta-carotene; zeta-Carotene; Zeta-Carotin; 7,8,7',8'-tetrahydro-psi,psi-carotene; LS-187678; LMPR01070256; 13587-06-9; CHEBI:27362;ζ-carotene	C40H60	540.9 g/mol	CC(=CCCC(=CCCC(=CC=CC(=CC=CC=C(C)C=CC=C(C)CCC=C(C)CCC=C(C)C)C)C)C)C

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000023		Skin and Connective Tissue Diseases; Immune System Diseases	Abnormality of the immune system	Disease or Syndrome	disease
TCMBANKDI000054		Nervous System Diseases; Mental Disorders	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI001795		Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases	-	Injury or Poisoning	disease
TCMBANKDI003353		Pathological Conditions, Signs and Symptoms; Neoplasms	-	Neoplastic Process	phenotype
TCMBANKDI003411		-	-	Disease or Syndrome	disease
TCMBANKDI004576		Mental Disorders	-	Mental or Behavioral Dysfunction	disease
TCMBANKDI006328		-	Abnormality of the genitourinary system	Disease or Syndrome	phenotype
TCMBANKDI007618		Hemic and Lymphatic Diseases	Abnormality of blood and blood-forming tissues	Disease or Syndrome	phenotype
TCMBANKDI009216		Behavior and Behavior Mechanisms	-	Mental Process	phenotype
TCMBANKDI011883		-	-	Mental Process	phenotype
TCMBANKDI015156		Pathological Conditions, Signs and Symptoms	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease
TCMBANKDI015485		Mental Disorders	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease
TCMBANKDI016247		-	-	Disease or Syndrome	disease
TCMBANKDI016946		Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Respiratory Tract Diseases	-	Disease or Syndrome	disease
TCMBANKDI017700		Digestive System Diseases	Abnormality of the digestive system	Disease or Syndrome	disease
TCMBANKDI022702		Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases	Abnormality of the nervous system	Congenital Abnormality	disease
TCMBANKDI027577		Cardiovascular Diseases	Abnormality of the cardiovascular system	Disease or Syndrome	group
TCMBANKDI027853		Infections; Immune System Diseases	-	Disease or Syndrome	disease
TCMBANKDI029321		Cardiovascular Diseases	-	Disease or Syndrome	group